LATEST NEWS
TRENDING NEWS
- EG 427 announces €12 million Series A financing to advance its HSV-1 based gene therapy
- McKesson Begins Distributing the Johnson & Johnson COVID-19 Vaccine
- LEXEO Therapeutics Announces License Agreement and Consolidation of Comprehensive Pre-clinical Data Package to Support Cardiac Friedreich’s Ataxia Gene Therapy Program (LX2006)
- New NCCN Guidelines for Histiocytosis Clarify Best Practices for Recently-Defined Cancers
- HealthTree Foundation Unveils ‘Cure in Five’ Initiative for Multiple Myeloma Awareness Month
- Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” Featuring GeoVax’s CEO & CFO On March 3, 2021
- Publix Pharmacies to Offer Doses of the COVID‑19 Vaccine at 58 South Carolina Stores
- Athenex Receives FDA Complete Response Letter for Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer
- Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies
- Entanglement Takes a “Quantum Leap” Towards Transparent Vaccine Distribution
